- Atopic dermatitis, the most prevalent type of eczema, can cause itchy skin and rashes that impair a person’s quality of life.
- Topical therapy, such as corticosteroid creams, can help alleviate symptoms of mild-to-moderate atopic dermatitis, but uncontrolled moderate-to-severe symptoms may also require oral or injectable drugs.
- A number of oral and injectable drugs are available for moderate-to-severe atopic dermatitis and determining factors influencing patient outcomes can help inform physicians’ decisions about treatments for the management of this skin condition.
- A recent study shows that patients with moderate-to-severe dermatitis who experienced the most rapid and significant reduction in itch levels and a greater reduction in affected body area were more likely to be satisfied with the treatment.
Atopic dermatitis is the most common form of eczema. It affects 16 million adults in the United States.
Depending on the severity, atopic dermatitis can negatively impact a person’s health and quality of life.
Numerous treatments are available for moderate-to-severe atopic dermatitis, but there is a lack of sufficient data comparing these treatments.
A study, which hasn’t been published yet in a peer review journal, was presented at the 5th Annual Revolutionizing Atopic Dermatitis Conference (RAD 2023).
In it, researchers reported that people were more likely to express satisfaction with treatments that produced the lowest levels of itch and the quickest onset of reduction in itchiness as well as ones that led to the largest decline in skin surface affected by atopic dermatitis.
Experts say these criteria that influence patient satisfaction with treatments for moderate-to-severe dermatitis can be used to inform shared decision-making in the clinic.
“The study’s findings highlight the importance of considering both the degree and speed of symptom improvement in atopic dermatitis treatment. As dermatologists, we recognize that addressing these factors is vital…
Read the full article here